Dysthymic Disorder

Among the various clinical entities related to depression, dysthymic disorder, also known as dysthymia, represents a chronic and persistent form of depression, characterized by symptoms that are less intense than those of major depressive disorder but persist over time. It is the second most common type of depressive mood disorder and is often underestimated due to its insidious and gradual onset.

The term dysthymia, or dysthymic disorder, was used in the DSM up to the IV-TR edition and is still employed clinically. However, it has been revised in the DSM-5, where the term persistent depressive disorder formally replaced "dysthymia," while retaining the same core clinical features. The aim was to simplify nosology and provide continuity for chronic depressive conditions.
Depending on the clinical context and diagnostic classification, it may also be referred to as:

• Chronic depression – a generic term often used in clinical practice to describe long-lasting persistent depression.
• Neurotic depression – a historical, now outdated definition once used for chronic depressive disorders without psychotic symptoms.
• Persistent minor depression – occasionally used to differentiate dysthymia from chronic major depressive disorder, particularly when symptoms are milder.
• Persistent depressive disorder – the official DSM-5 term encompassing both classic dysthymia and chronic forms of major depressive disorder lasting more than two years.

Its main feature is the presence of a depressed mood for most of the day, nearly every day, for at least two consecutive years in adults (one year in children and adolescents), accompanied by at least two of the following symptoms:

• Poor appetite or, conversely, overeating
• Insomnia or hypersomnia
• Low energy or fatigue
• Low self-esteem
• Poor concentration or difficulty making decisions
• Feelings of hopelessness or chronic pessimism

During this period, symptom-free intervals must last less than two months. Otherwise, a diagnosis of dysthymia is not applicable.

For diagnosis, it is essential that there has never been a manic, hypomanic, or mixed episode, nor that criteria are met for cyclothymic disorder. The diagnosis must also rule out symptoms due to the direct effects of psychoactive substances, medications, or organic diseases (such as thyroid dysfunction, anemia, cancer, or neurological disorders).

The main differential diagnosis is with chronic major depressive disorder. If a major depressive episode occurs during the first two years without a complete remission lasting at least two months, a diagnosis of dysthymia cannot be made. Conversely, if a major depressive episode arises after the initial two years of dysthymic symptoms, both diagnoses apply.

Clinical Course and Functional Impact

Dysthymia has an insidious and persistent course, often beginning in childhood, adolescence, or early adulthood, and may last for decades. Individuals tend to perceive their dysphoric mood as an integral part of their personality, developing a “habitual depressive style”. This leads to significant impairment in social relationships, emotional life, and professional achievement, although it does not necessarily result in the acute disability seen in major depressive disorder.

Dysthymic disorder is frequently associated with other psychiatric conditions, especially anxiety disorders, substance use disorders, and personality disorders (particularly borderline and avoidant types). This comorbidity worsens the prognosis and complicates treatment response.

Based on age of onset, two subtypes are distinguished:

• Early-onset dysthymic disorder: symptoms present before age 21, often associated with higher psychiatric comorbidity and lower treatment response
• Late-onset dysthymic disorder: symptoms appearing after age 21

In some cases, the disorder may be further specified as with atypical features, if the criteria for this specifier have been met during the last two years.

Although dysthymia presents with milder symptoms than major depression, it significantly compromises quality of life and has a high impact on overall functioning. Often unrecognized or mistaken for a personality trait, it requires specific clinical attention, timely diagnosis, and targeted treatment strategies, including both pharmacological and psychotherapeutic approaches.

References
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition – Text Revision (DSM-IV-TR). American Psychiatric Press. 2000.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Publishing. 2013.
3. Sadock BJ, Sadock VA. Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Wolters Kluwer. 2014.
4. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Archives of General Psychiatry. 1992;49(10):809–816.
5. Angst J, Gamma A, Rössler W, et al. Long-term depression versus episodic major depression: results from the prospective Zurich study of a community sample. Journal of Affective Disorders. 2009;115(1-2):112–121.
6. Hellerstein DJ, Markowitz JC, McGrath PJ. Dysthymic disorder: a review of pharmacological and psychotherapeutic approaches. Journal of Clinical Psychiatry. 1997;58(8):346–353.
7. Markowitz JC, Bleiberg KL. Dysthymic disorder: an overview and future directions. Journal of Clinical Psychiatry. 2000;61(Suppl 10):9–13.
8. Thase ME. Dysthymia and double depression: current concepts and treatment. Journal of Clinical Psychiatry. 1997;58(Suppl 6):8–13.
9. Riso LP, Thase ME. Psychological treatment of dysthymia: a review of research. Clinical Psychology Review. 2000;20(5):685–706.
10. Spijker J, de Graaf R, Bijl RV, et al. Determinants of persistence of major depressive episodes in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Journal of Affective Disorders. 2004;81(3):231–240.